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Autophagy is a catabolic process that ensures ho-
meostatic cell clearance and is deregulated in a
growing number of myopathological conditions.
Although FoxO3 was shown to promote the expres-
sion of autophagy-related genes in skeletal muscle,
the mechanisms triggering autophagy are unclear.
We show that TSC1-deficient mice (TSCmKO), char-
acterized by sustained activation of mTORC1,
develop a late-onset myopathy related to impaired
autophagy. In young TSCmKO mice, constitutive
and starvation-induced autophagy is blocked at the
induction steps via mTORC1-mediated inhibition of
Ulk1, despite FoxO3 activation. Rapamycin is suffi-
cient to restore autophagy in TSCmKO mice and
improves the muscle phenotype of old mutant
mice. Inversely, abrogation of mTORC1 signaling by
depletion of raptor induces autophagy regardless
of FoxO inhibition. Thus, mTORC1 is the dominant
regulator of autophagy induction in skeletal muscle
and ensures a tight coordination of metabolic path-
ways. These findings may open interesting avenues
for therapeutic strategies directed toward auto-
phagy-related muscle diseases.
INTRODUCTION
Muscle wasting, a hallmark of genetic and acquired muscle
pathologies, is also associated with aging, cancer, AIDS, and
chronic diseases of the heart, lung, or kidney. Muscle size
depends on the balance between protein synthesis and protein
degradation, the latter being ensured by the ubiquitin-protea-
some pathway and the autophagy process (Ru¨egg and Glass,
2011). Despite the identification of the main molecular pathways
involved in the regulation of this homeostatic balance, our under-
standing of the integrated signaling network remains limited.CMuscle growth is a costly process restricted to optimal
nutrient and energy availability. The mammalian target of
rapamycin complex 1 (mTORC1), which includes mTOR and
regulatory associated protein of mTOR (raptor), is a conserved
regulator of cell growth that integrates cellular inputs to ensure
translation, lipid synthesis, and organelle biogenesis (Laplante
and Sabatini, 2012). Most of these signals converge on the
heterodimer TSC1/TSC2 (tuberous sclerosis complex 1 and 2)
that functions as a GTPase-activating protein for the mTORC1
activator, the Ras-related binding protein Rheb (Inoki et al.,
2003; Tee et al., 2003). Sensing of amino acids is, by contrast,
independent of TSC1/TSC2 but mediated by the Ragulator-
Rag complex that recruits mTORC1 to lysosomal membranes
and promotes its activation by Rheb (Sancak et al., 2010).
Macroautophagy, hereafter referred to as autophagy, is
involved in the constitutive turnover of organelles andmacromol-
ecules, as well as in the adaptive degradation of cellular compo-
nents in response to different stresses such as low nutrient or
energy supply. Upon autophagy induction, double-membrane
vesicles, called autophagosomes, engulf large parts of the cyto-
plasm and release degraded components following fusion with
lysosomes, thus ensuring metabolite recycling (Lum et al.,
2005). In most cell types, autophagy induction relies on the
release of the inhibition of the Ulk1-Atg13-FIP200 complex by
mTORC1 (Kim et al., 2011). By contrast, in skeletal muscle,
autophagy was suggested to be independent of mTORC1 but
controlled by the forkhead box O3 protein (FoxO3), which pro-
motes the transcriptional induction of atrogenes (notably encod-
ing the E3 ubiquitin ligases atrogin1/MAFbx and MuRF1) and
autophagy-related genes (Mammucari et al., 2007; Zhao et al.,
2007).
In contrast to this apparent clear-cut separation between
mTORC1-dependent anabolism and FoxO-dependent catabo-
lism, integration of the entire regulatory network responsible
for muscle homeostasis appears to be more complicated. In
particular, the common control of mTORC1 and FoxO pathways
by the upstream Akt protein and the existing feedback loops
make it difficult to predict the physiological consequences of
their modulation. We previously showed that inactivation of
mTORC1 in skeletal muscle by deleting raptor (RAmKO mice)ell Metabolism 17, 731–744, May 7, 2013 ª2013 Elsevier Inc. 731
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activation of Akt promotes muscle growth. Although this effect
can be blocked by rapamycin, the contribution of the inhibition
of FoxO-dependent catabolism to this hypertrophy response is
not clear (Bodine et al., 2001; Lai et al., 2004). Importantly, dele-
tion of Tsc1 in skeletal muscle (TSCmKO mice), which leads to
simultaneous activation of mTORC1 and FoxO pathways,
causes atrophy of most muscles (Bentzinger et al., 2013).
Here, we investigated the relative importance of mTORC1 and
FoxO signaling for muscle homeostasis and their role in the regu-
lation of autophagy. We show that sustained activation of
mTORC1 in TSCmKO mice leads to a severe, late-onset pheno-
type reminiscent of myopathies caused by impaired autophagy.
Despite simultaneous activation of FoxO3 signaling in TSCmKO
mice, induction of constitutive and starvation-dependent auto-
phagy is inhibited in mutant animals. This autophagy blockade
and the myopathy of old TSCmKO mice are largely reversible
by rapamycin. We also establish that mTORC1 inactivation, in
RAmKO mice, is sufficient to induce autophagy. Our data thus
demonstrate that mTORC1 is the dominant regulator of auto-
phagy in skeletal muscle.
RESULTS
TSCmKO Mice Develop a Severe, Late-Onset Myopathy
TSCmKO mice, obtained by deleting Tsc1 specifically in muscle
tissues and characterized by constant activation of the mTORC1
pathway, are macroscopically indistinguishable from control
animals at an early age (Bentzinger et al., 2013). However, after
9 months of age, mutant mice developed a severe kyphosis (Fig-
ure 1A) and eventually died around one year of age (data not
shown). They were significantly lighter than control mice, which
was largely related to a loss in fat and lean body mass (Table 1).
Like in young mutant mice (Bentzinger et al., 2013), tibialis ante-
rior (TA), extensor digitorum longus (EDL), quadriceps, and
gastrocnemius muscles from 12-month-old TSCmKO mice
were lighter than in control mice, while soleus was significantly
heavier (Table 1). The mTORC1 pathway remained activated in
12-month-old TSCmKO mice as indicated by the increased
phosphorylation of the mTORC1 target ribosomal protein S6
(Figure S1A). Moreover, phosphorylation of Akt was dampened
(Figure S1A), consistent with the negative feedback loop exerted
by mTORC1 signaling onto IRS1 (Harrington et al., 2004;
Bentzinger et al., 2008).
The loss of fat and lean body mass in old TSCmKO mice was
due to the genetic depletion of TSC1 in muscle, as TSC1 expres-
sion and/or the levels of phospho-S6 were not modified in other
tissues such as liver, fat, or kidney (Figure S1A). Although levels
of blood glucose were slightly lower in old TSCmKOmice than in
age-matched controls, insulin levels and the two cachexia
markers TNFa and IL6 (Spa¨te and Schulze, 2004; Tisdale,
2010) were not significantly changed (Figure S1B).
Histological examination of muscles from 12-month-old
TSCmKO mice revealed vacuolated fibers, basophilic fibers,
and intracellular inclusions (Figures 1B and S1C). Most inclu-
sions were positive for acid phosphatase, nicotinamide adenine
dinucleotide (NADH), and COX, but were devoid of adenosine
triphosphatase (ATPase) activity, indicating the presence of
mitochondria, sarcoplasmic reticulum, and lysosomes and the732 Cell Metabolism 17, 731–744, May 7, 2013 ª2013 Elsevier Inc.loss of myofibrillar elements in these regions (Figure S1D). As
reported in human vacuolar myopathies (De Bleecker et al.,
1993), some, but not all, vacuoles were positive for sarcolemmal
components such as dystrophin or b-dystroglycan (Figure S1E).
Abnormally large myonuclei were often observed in hematoxylin
and eosin (H&E)-stainedmuscle sections (Figure 1B) or by immu-
nohistological staining with anti-lamin C antibody (Figure 1C).
These pathological changes in skeletal muscle were absent in
3-month-old mice but became visible in 6-month-old TSCmKO
mice (Figure S1F).
Ultrastructural analysis by electron microscopy confirmed the
presence of enlarged myonuclei and vacuoles in EDL and soleus
muscles from 9-month-old TSCmKO mice (Figure 1D). Contrac-
tile compartments of some muscle fibers were shrunken with an
enlarged peripheral region containing giant and vacuolated
mitochondria or accumulation of aberrant membrane structures
(Figures 1D and S1G). Sarcomeres were sometimes disorga-
nized with accumulation of mitochondria (Figure S1G).
Immunostaining against type I and II myosin heavy chain
(MHC) on TA sections from 12-month-old TSCmKO mice re-
vealed a marked atrophy of type IIb fibers, whereas type IIa/IIx
fibers were significantly hypertrophic (Figure 1E). The number
of fibers and the fiber-type proportions were unchanged
compared to control (data not shown). In soleus, type I fibers
were significantly smaller than in control mice, whereas type
IIa/IIx fibers varied from atrophic to hypertrophic fibers (Fig-
ure 1F). Such atrophic fibers likely resulted from fiber splitting,
consistent with an increased number of fibers in soleus from
12-month-old mutant mice compared to controls (data not
shown).
To determine whether the pathological changes correlated
with impaired muscle function, we measured the in vitro force
of the atrophic EDL and the hypertrophic soleus from 12-
month-old mice. As shown in Table 1, specific twitch (sPt) and
tetanic (sPo) forces were reduced to less than 50% in both
mutant muscles compared to controls. Thus, constant activation
of mTORC1 results in muscle weakness that is decoupled from
muscle size. A similar decline in sPt and sPo was found in soleus
from 3-month-old TSCmKO mice, indicating that the loss of
muscle force precedes the detection of the myopathic alter-
ations (Table 1).
Together, these observations indicate that sustained activa-
tion of mTORC1 in skeletal muscle results in a multifaceted
myopathy characterized by the presence of vacuoles and the
accumulation of abnormal organelles.
Muscle Alterations in TSCmKO Mice Are Related
to Impaired Autophagy
The similarity of the phenotype to mice with impaired autophagy
(Masiero et al., 2009) prompted us to evaluate autophagy
markers in TSCmKO mice at different ages. Because Akt was
inhibited in TSCmKO mice, one could expect activation of
FoxO3 signaling, another regulator of autophagy (Mammucari
et al., 2007; Zhao et al., 2007). Nonetheless, we did not detect
a major decrease in the phosphorylation of FoxO1/FoxO3 pro-
teins in muscles from 6- or 12-month-old mutant mice (Fig-
ure 2A), and expression of MuRF1 and Atrogin1, which were
significantly induced in TA from 3-month-old mice, was not
changed in older mutant mice (Figure 2B and data not shown).
Figure 1. TSCmKO Mice Develop a Late-Onset Phenotype with Severe Muscle Alterations
(A) TSCmKO mice display severe kyphosis at 9 months of age.
(B) H&E and NADH stains reveal accumulation of vacuolated (arrow) and basophilic (asterisk) fibers, intracellular inclusions (open arrow), and abnormally large
myonuclei (arrowhead) in TA muscle from 12-month-old TSCmKO mice. Scale bar = 50 mm.
(C) Immunostaining against lamin-C and laminin reveals giant nuclei in muscle from 12-month-old TSCmKO mice. Scale bar = 20 mm.
(D) Electron micrographs show inflated myonuclei (i), vacuoles (ii), intracellular accumulation of abnormal mitochondria (iii), and aberrant membrane structures
(iv) in muscles from 12-month-old TSCmKO mice. The dotted line in (iii) indicates the limit of the contractile region of the fiber. Scale bar = 2 mm.
(E and F) Fiber size distribution in TA (E) and soleus (F) from 12-month-old TSCmKO mice reveals atrophy of type IIb and I fibers and hypertrophy of type IIa/IIx
fibers. Values are mean ± SEM; *p < 0.05, **p < 0.005, ***p < 0.0005.
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Table 1. TSCmKO Mice Are Characterized by Reduction in Body
Weight and in Muscle Force
Ctrl TSCmKO
Body mass (g)
Whole body 24.2 ± 0.7 19.6 ± 0.5***
Lean 16.8 ± 0.3 14.9 ± 0.38***
Fat 4.8 ± 0.5 2.2 ± 0.1***
Muscle mass (mg)
TA 53.2 ± 1.9 44.0 ± 3.2*
EDL 13.6 ± 0.6 9.3 ± 0.6**
Quadriceps 212.8 ± 5.9 178.4 ± 14.9
Gastrocnemius 138.6 ± 5.7 95.6 ± 6.3**
Soleus 10.3 ± 0.9 13.8 ± 0.7**
Specific Twitch Force (sPt; mN/mm2)
3 month EDL 51.4 ± 2.3 42.7 ± 6.6
Soleus 45.6 ± 4.2 11.9 ± 1.3***
12 month EDL 38.9 ± 3.7 16.0 ± 4.6**
Soleus 37.4 ± 3.1 10.2 ± 3.1***
Specific Tetanic Force (sPo; mN/mm2)
3 month EDL 480.0 ± 22.7 328.8 ± 68.8
Soleus 390.4 ± 11.4 185.3 ± 16.3***
12 month EDL 355.0 ± 22.8 120.0 ± 10.3***
Soleus 316.2 ± 12.3 86.6 ± 20.0***
Body and muscle masses are given for 12-month-old TSCmKO and con-
trol (Ctrl) mice. The lean and fat mass was measured by EchoMRI. TA,
tibialis anterior; EDL, extensor digitorum longus. p values determined
by Student’s t test are indicated by asterisks (n R 3). Values represent
mean ± SEM. *p < 0.05, **p < 0.005, ***p < 0.0005.
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the accumulation of which is used as a readout for autophagy
impairment (Klionsky et al., 2012). In 12-month-old TSCmKO
mice, p62 accumulated in the cytoplasm or as focal aggregates
in most muscle fibers (Figure 2C) irrespective of their fiber type
(data not shown). Basophilic cells and intracellular inclusions
located in the periphery of the cells were positive for p62,
whereas vacuoles and central inclusions were mostly negative
(Figure S2A). p62 levels were increased in both the detergent-
soluble and -insoluble fractions from TA and soleus muscles,
confirming the presence of aggregates in muscle fibers (Fig-
ure 2D and data not shown). Concomitantly, levels of ubiquitiny-
lated proteins were increased in muscles from 12-month-old
TSCmKO mice and p62 aggregates were generally positive
for ubiquitin (Figures S2B and S2C). p62 also accumulated in
muscle from younger TSCmKOmice (Figure 2D), but aggregates
were not detected in 3-month-old mice and were less frequent in
6-month-old mice than in 12-month-old animals (Figure 2C). This
indicates that p62 accumulates prior to morphological muscle
alterations.
Because accumulation of p62 is a hallmark of impaired auto-
phagy flux, we next evaluated levels of the soluble (LC3I) and
autophagosome-associated (LC3II) forms of the widely used
LC3 (microtubule-associated protein light chain 3) autophagy
marker. The conversion of LC3I to LC3II is representative of
the accumulation of autophagosomes in cells (Klionsky et al.,734 Cell Metabolism 17, 731–744, May 7, 2013 ª2013 Elsevier Inc.2012). In TA from 3- and 6-month-old TSCmKO mice, levels of
LC3I were increased compared to control, while both LC3I and
LC3II forms tended to accumulate in 12-month-old TSCmKO
mice. By contrast, LC3I and LC3II were not altered in soleus
muscles (Figure 2D). It is noteworthy that lysosome-related ves-
icles, marked with the lysosomal-associated membrane protein
1 or 2 (Lamp1/Lamp2), also accumulated in muscle fibers from
12-month-old TSCmKO mice, especially at the periphery of the
cells and around myonuclei (Figures 2E and S2D). These lyso-
somal structures rarely colocalized with p62 aggregates (Fig-
ure S2E). Expression of Cathepsin L, a lysosomal enzyme
involved in the degradation of autophagic content, was
increased in TA and even more so in soleus from TSCmKO
mice at all ages (Figure 2D). Transcript levels of Cathepsin L
and p62 were increased in TA and soleus muscles from
3-month-old TSCmKO mice, consistent with FoxO activation,
but their expression normalized in older mice, as observed for
MuRF1. LC3 messenger RNA (mRNA) levels were not changed
at any age (Figures 2F and 2G). Together with the morphological
alterations described above, these observations indicate that
autophagy is perturbed in TSCmKO mice.
Induction of Constitutive and Starvation-Dependent
Autophagy Is Blocked in Skeletal Muscle from TSCmKO
Mice
To better understand the autophagy-related defects detected in
TSCmKO mice, we explored the ability of 2-month-old mutant
mice to increase autophagy flux in muscle when submitted to
a physiological stimulus like fasting (Mizushima et al., 2004). To
distinguish between constitutive and starvation-induced auto-
phagy, mice were examined in fed or basal conditions and
following food deprivation (starved). Fed mice were sacrificed
in the late evening when they were actively eating, while
basal conditions refer to the early morning during the light-on
circadian period. Fed mice showed activation of Akt and S6
similar to mice that were fasted overnight and then refed for
4 hr in the morning (data not shown). In control muscle, auto-
phagy was induced in basal conditions, as shown by the conver-
sion of LC3I to LC3II, compared to fed conditions (Figure S3A).
This induction of autophagy correlated with Akt/mTORC1 inhibi-
tion (Figure S3A), whereas transcription of the main autophagy-
related genes remained unchanged (Figure S3B). After 24 or
48 hr of starvation, autophagy was greatly induced, as reflected
by a major increase in the LC3II/LC3I ratio (Figure S3A), and was
paralleled by upregulation of autophagy-related genes (Fig-
ure S3B). Levels of phospho-Akt and phospho-S6 were not
significantly reduced compared to basal conditions (Figure S3A).
In stark contrast to controls, TSCmKO mice showed constant
high phosphorylation of S6 and low levels of phospho-Akt
regardless of their nutritional status (Figure 3A). Interestingly,
the energy-sensing 50 AMP-activated protein kinase (AMPK)
was similarly activated upon starvation in control and mutant
mice (Figure S3C). Starvation increased the percentage of
myonuclei positive for FoxO3, indicative of its active state (Fig-
ure S3D); mRNA expression of MuRF1 and Atrogin1 (Figure 3B)
was also increased in TA muscle of control and TSCmKO mice.
It should be noted, however, that the percentage of FoxO3-
positive myonuclei was higher in TSCmKO mice than in controls
in both basal and starved conditions (Figure S3D). These results
Figure 2. Autophagy Flux Is Impaired in TSCmKO Muscles
(A) Immunoblots of TA and soleusmuscles from 12-month-old TSCmKO (TSC) and control (Ctrl) mice are shown for the indicated phospho (P)- and total proteins.
(B)MuRF1mRNA expression was quantified by qPCR in TA and soleus from 3-, 6-, and 12-month-old (M, month) TSCmKO and control mice and normalized to
b-actin expression. Levels are presented as mean ± SEM relative to 3-month-old control mice; *p < 0.05.
(C) p62 accumulates within the cytoplasm or as focal aggregates in muscle fibers from 6- and 12-month-old (M, month) TSCmKO mice. Scale bar = 50 mm.
(D) Immunoblots for autophagy-related proteins reveal impaired autophagy flux in TA and soleusmuscles from TSCmKO (TSC) mice at different ages compared
to control (Ctrl). The proprotein (37 kDa), intermediate (30 kDa), and mature (25 kDa) forms of Cathepsin L are shown. Data are normalized to a-actinin and
represent at least three independent experiments; quantification is given in Table S1. M, month.
(E) Lysosomal vesicles stained with anti-Lamp2 antibody accumulate in muscle fibers, especially in the periphery of muscle fibers (arrow) and around myonuclei
(open arrow) in 12-month-old (M, month) TSCmKO mice, but not in control (Ctrl) animals. Scale bar = 50 mm.
(F and G) Expression of some autophagy-related genes is significantly increased in TA (F) and soleus (G) from 3-month-old TSCmKO mice compared to control
mice. This difference becomes less prominent in 6- and 12-month-old mice. Values are mean ± SEM of data normalized to b-actin levels; *p < 0.05. M, month.
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activation of AMPK in TSCmKOmice. Together, these data sup-
port the idea that starvation-induced activation of FoxO3 not
only depends on Akt inhibition, but further requires AMPK activa-
tion, consistent with recent in vitro results obtained in muscle
cells (Sanchez et al., 2012).
When TSCmKO mice were starved for 12, 24, or even 48 hr,
loss of body weight was comparable to that in control miceC(data not shown). Starvation did not lead to major muscle alter-
ations in mutant mice, although a few fibers from soleus mus-
cle of TSCmKO mice contained small vacuoles and abnormally
large myonuclei that were not observed in control mice or fed
mutant mice (Figure S3E). Starvation increased the levels of
p62 protein in mutant muscle (Figure 3A), but the protein did
not form large aggregates like in 12-month-old mice (Fig-
ure S3F). Interestingly, in TA muscle from TSCmKO mice, levelsell Metabolism 17, 731–744, May 7, 2013 ª2013 Elsevier Inc. 735
Figure 3. Autophagy Induction Is Blocked in TSCmKO Muscles
(A) Two-month-old TSCmKO (TSC) and control (Ctrl) mice were examined in fed, basal, and starved (St24 or St48 hr) conditions. Immunoblots using antibodies to
detect Akt and S6 protein, specific phosphorylation sites (P) in the respective proteins, and autophagy-related proteins show that mutant TA muscle was
resistant to starvation-mediated autophagy induction. Data are normalized to a-actinin and representative of three independent experiments; for quantification,
see Table S2.
(B) Transcript expression of MuRF1 and Atrogin1 is efficiently upregulated in TA from TSCmKO mice after 24 or 48 hr of starvation (St). Expression levels are
normalized to b-actin. Values are mean ± SEM; $p < 0.05, $$p < 0.005 compared to same genotype in basal conditions.
(C and D) TSCmKOmice expressing GFP-LC3 display a reduced number of GFP-positive puncta in TA muscle compared to control (Ctrl) after 24 hr of starvation
(St24) (C). This effect is confirmed by quantifying the number of GFP-LC3 puncta in a volume unit (Vol) of 3.63 105 mm3 (D). Data are mean ± SEM; ***p < 0.0005.
Scale bar = 50 mm.
(E) Treatment with chloroquine (+) leads to only amild increase in LC3II levels in TAmuscle from starved TSCmKO (TSC)mice, indicating that LC3I accumulation in
these mice is due to impaired induction steps.
(F) Expression of autophagy-related genes is upregulated after 24 or 48 hr of starvation (St) in TA from TSCmKO mice. Data are normalized to b-actin levels and
relative to control mice in basal conditions. Values are mean ± SEM; *p < 0.05, **p < 0.005 compared to control mice in the same condition; $p < 0.05, $$p < 0.005,
$$$p < 0.0005 compared to same genotype in basal conditions.
(G and H) Overexpression of the Ulk1 mutant S757A, together with construct expressing tdRFP, restores the induction of GFP-LC3 puncta in electroporated
TSCmKO fibers (*) (G); quantification of the results are shown in (H). No effect is observed with the empty plasmid or in control (Ctrl) muscle. Scale bar = 10 mm. A
volume unit (Vol) is 3.6 3 103 mm3. Values are mean ± SEM. *p < 0.05; **p < 0.005.
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and starved conditions (even after prolonged fasting for
48 hr), and they were comparable to those observed in fed
control mice (Figure 3A). To confirm this result, we crossed
TSCmKO mice with GFP-LC3 transgenic mice (Mizushima
et al., 2004) and examined the number of green fluorescent
protein (GFP)-positive puncta, representative of autophago-
somes, in control and mutant muscle. In basal conditions, the
number of GFP-LC3 puncta in TA was similar in TSCmKO
and control mice. However, the number of GFP-LC3 puncta
did not increase in TSCmKO muscles after 24 hr of starvation,
while, as expected, the number of puncta more than doubled in
control mice (Figures 3C and 3D). These results are consistent
with either a blockade in autophagy induction or an excessive
exhaustion of the vesicles. To discriminate between the two
possibilities, starved mice were treated with chloroquine, a
lysosomal inhibitor that prevents the degradation of the auto-
phagic content. While chloroquine treatment strongly increased
LC3II levels in control mice, LC3II was only slightly increased in
TSCmKO mice, indicating that the reduced number of autopha-
gosomes in mutant muscles is due to impaired autophagy in-
duction (Figure 3E).
We next addressedwhether this defect in autophagy induction
was caused by abnormal expression of autophagy-related
genes (Mammucari et al., 2007). Consistent with FoxO being
active, mRNA expression of Cathepsin L, p62, Gabarapl1, and
Bnip3 was efficiently increased after 24 or 48 hr of starvation in
TSCmKO mice compared to control mice (Figures 3F and
S3G). Cathepsin L and the two positive regulators of autophagy,
Bnip3 and Beclin 1, also showed normal or higher protein
expression in mutant mice (Figure S3C). Similar results were
obtained in soleus muscle (Figures S3H and S3I). These results
show that sustained activation of mTORC1 blocks the induction
of constitutive and starvation-induced autophagy despite FoxO3
activation.
In cultured cells, mTORC1 has been shown to phosphorylate
Ulk1 and thereby inhibit its activation by AMPK (Kim et al.,
2011). We therefore assessed the phosphorylation state of
Ulk1 in TSCmKOmuscles and found that the amount of the inac-
tive, phosphorylated form of Ulk1 at S757 was markedly
increased in all conditions compared to control, while there
was no major change in the AMPK-dependent phosphorylation
at S317 of Ulk1 in mutant mice (Figure 3A). To test whether this
hyperphosphorylation of Ulk1 was responsible for the effect on
autophagy, TA muscles from control and TSCmKO mice were
coelectroporated with a tandem-dimer (td) red fluorescent pro-
tein (RFP) expression construct and a plasmid encoding the
Ulk1 mutant S757A, which is insensitive to mTORC1 (Kim
et al., 2011). After 8 days and starvation of the mice for the final
36 hr, the number of GFP-LC3 puncta was significantly higher in
RFP-positive fibers compared to RFP-negative fibers in
TSCmKO muscle and became similar to that detected in control
muscle (Figures 3G and 3H). Similar results were obtained when
the wild-type form of Ulk1 was electroporated into TA muscle
(Figure S3J). In contrast, no effect was observed using the empty
plasmid, and electroporation of empty vector or Ulk1 encoding
plasmid into control muscle did not affect the number of GFP-
LC3 puncta (Figure 3G and 3H). These results indicate that
mTORC1 mediates its inhibitory function on autophagy viaCUlk1 and that restoration of Ulk1 is sufficient to normalize auto-
phagy in TSCmKO muscle.
Hyperactivation of mTORC1 Is Sufficient to Block
Autophagy Both In Vivo and In Vitro
To test whether acute depletion of the TSC complex could also
block autophagy, we electroporated control muscles with small
hairpin RNA (shRNA) constructs directed against Tsc1 and Tsc2
together with tdRFP expression plasmids. After 8 days, muscles
were examined following starvation of the mice for the last 36 hr.
Compared to muscle electroporated with control shRNA to Cd4,
knockdown of Tsc1/Tsc2 in soleus muscle resulted in lower
levels of TSC1 and TSC2 and higher levels of phospho-S6 (Fig-
ure 4A). Indicative of reduced autophagy induction, the LC3II/
LC3I ratio was reduced (Figure 4A) and the number of GFP-
LC3 puncta was significantly decreased in RFP-positive fibers
of TA muscle electroporated with Tsc1/Tsc2 shRNA compared
to RFP-negative fibers in the same muscle (Figures 4B and
4C). No effect was detected with control shRNA directed against
Cd4. In a similar experiment, when examining soleus muscle
4 weeks after electroporation of shRNA directed against Tsc2
together with an expression construct for nuclear GFP (nuGFP),
TSC2 levels were reduced and high levels of phospho-S6 were
detected (Figure 4D). Notably, the amount of p62 was increased
in the examined muscles, and p62 accumulation was further
observed by immunostaining in nuGFP-positive fibers express-
ing Tsc2 shRNA (Figure 4E). These results demonstrate that
autophagy is also impaired following acute perturbation of
mTORC1 signaling in adult mice.
In an additional step, we investigated whether sustained acti-
vation of mTORC1 would impair autophagy in vitro by isolating
single fibers from EDL muscle of TSCmKO mice expressing
GFP-LC3. Compared to fibers placed in growth medium, a
strong increase in the number of GFP-positive puncta was
observed when control fibers were incubated with medium
depleted of amino acids and glucose. In contrast, the number
of GFP-LC3 puncta remained low in TSCmKO fibers even after
amino acid and glucose depletion (Figures 4F, 4G, and S4A). In
addition, control fibers contained large, Lamp2-positive vesicles
after starvation, whereas only few such structures could be de-
tected in TSCmKO fibers (Figure 4F). Levels of p62 were slightly
increased inmutant fibers compared to control, and as observed
in vivo, TSCmKO fibers maintained high levels of phospho-S6
and low levels of phospho-Akt irrespective of the culture condi-
tions (Figures 4H and S4B). These results demonstrate that the
release of TSC1/TSC2 inhibition onto mTORC1 is sufficient to
fully activate the pathway both in vivo and in vitro, hence con-
trasting with in vitro evidence suggesting that amino acid supply
is absolutely required for mTORC1 activation, irrespective of
other positive stimuli (Smith et al., 2005).
Inactivation of mTORC1 Promotes LC3 Lipidation
in Spite of FoxO Inhibition
Having established that sustained activation of mTORC1 impairs
autophagy, we asked whether its inactivation would promote the
autophagy flux by examining the response of 2-month-old
RAmKO mice to food deprivation. Mutant mice displayed
reduced phospho-S6 levels in fed, basal, and starved conditions
compared to controls, in accordance with mTORC1 inactivationell Metabolism 17, 731–744, May 7, 2013 ª2013 Elsevier Inc. 737
Figure 4. Hyperactivation of mTORC1 Impairs Autophagy in Muscle Fibers
(A–C) Coelectroporation of tdRFP and shRNA constructs directed against Tsc1 and Tsc2 results in hyperactivation of mTORC1 signaling after 8 days (A) and in a
decreased number of GFP-LC3 puncta in transfected RFP-positive fibers (*) whenmicewere previously starved for 36 hr (B). GFP-LC3 punctawere quantified in a
volume unit (Vol) of 3.6 3 103 mm3 (C). Scale bar = 10 mm. Values are mean ± SEM. *p < 0.05.
(D and E) Four weeks after electroporating Tsc2 shRNA together with nuGFP in TA muscle, levels of phospho-S6 and p62 are increased compared to muscle
electroporated with control Cd4 shRNA (D). Accumulation of p62 is detected by immunostaining in nuGFP-positive fibers in muscle electroporated with Tsc2
shRNA (E). Scale bar = 50 mm.
(F andG) Single muscle fibers isolated fromGFP-LC3 expressing control mice (Ctrl) show induction of GFP-positive puncta and large Lamp2 vesicles (arrow) after
4 hr in glucose- and amino acid-deprived medium (St4) compared to fibers placed in growth medium (GM). These vesicles remain rare in fibers isolated from
TSCmKO mice (F). Quantification of the number of GFP-LC3 puncta/mm3 (G). Scale bar = 25 mm. Values are mean ± SEM.
(H) Immunoblots using antibodies that detect Akt and S6 protein and their phosphorylated forms reveal hyperactivation of mTORC1 signaling in TSCmKO fibers
(TSC) in growth medium (GM) and after 4 hr without glucose and amino acid (St4).
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FoxO1/FoxO3 (Figure S5A) was maintained at high levels
in starved mutant mice, and transcript levels of MuRF1 and
Atrogin1 were markedly lower than in starved control mice
(Figure 5B).
After 12 or 24 hr of starvation, a similar loss of body mass was
measured in RAmKO and control mice, and H&E staining
revealed no obvious muscle alterations compared to basal con-
ditions (data not shown). p62 protein accumulated in only a few
muscle fibers from starved mutant mice, although the number
and the size of these aggregates were increased compared to
basal conditions (Figure 5C). Western blot analysis revealed
similar low levels of p62 in TA frommutant and control mice (Fig-
ure 5D). Interestingly, elevated levels of LC3II, similar to those in
starved control mice, were detected in RAmKO muscle, regard-
less of the nutritive status of themice (Figure 5D). To further eval-
uate the number of autophagosomes in muscle fibers, RAmKO
mice were crossed with GFP-LC3 transgenic mice (Mizushima
et al., 2004). In basal conditions, the number of GFP-positive
puncta in TA sections fromRAmKOmice was significantly higher
compared to control mice and similar to the number in TA from
starved control mice (Figures 5E and 5F). After 24 hr of starva-
tion, the number of GFP-LC3 puncta was not further increased
in RAmKO mice, and we noticed that GFP-LC3 puncta were
not distributed homogeneously in mutant muscle compared to
control (Figure 5F). While in basal and starved conditions, chlo-
roquine treatment enhanced LC3II levels in both mutant and
control mice; in fed conditions, the amount of LC3II was only
increased in RAmKO mice, supporting the idea that autophagy
is permanently induced in mutant mice (Figure 5D). Contrasting
with this result, transcript levels of autophagy-related genes
were strongly reduced in muscles from starved mutant mice,
consistent with increased Akt-dependent inhibition of FoxO
compared to control mice (Figures 5G and S5B). Nevertheless,
expression of most autophagy-related genes was significantly
increased after starvation in mutant muscles, which could be
related to starvation-induced activation of AMPK (Figure S5A).
Cathepsin L, Cathepsin D, and Bnip3 protein levels were also
reduced in mutant mice compared to control animals, while no
major change was detected in the amount of Beclin 1 and phos-
pho-Ulk1S757 (Figures 5D and S5A). In contrast, phosphorylation
of Ulk1 at S317 was strongly increased in RAmKO mice, sug-
gesting that mTORC1 inactivation facilitates AMPK-dependent
activation of Ulk1 in muscle (Figure S5A). Similar results were
obtained in soleus muscle (Figures S5C and S5D). Together,
these data indicate that autophagy is induced in RAmKO
muscles despite reduced FoxO-dependent transcription of
autophagy genes.
To go further, autophagy markers were assessed in 6-month-
old RAmKO mice: like in 2-month-old mice, mRNA levels of
Cathepsin L, LC3, and Bnip3 were significantly decreased in
mutant mice, and the amount of LC3II was increased (Figures
S5E–S5G). In parallel, protein expression of Cathepsin L was
strongly reduced while the levels of Cathepsin D and Lamp1
were only slightly lowered in mutant TA muscle compared to
control (Figure S5G). No major difference was observed in the
acid phosphatase activity of RAmKO and control muscles,
except in regenerative fibers, which were strongly reactive to
the staining (Figure S5H). While p62 levels were unchanged inCdetergent-soluble and -insoluble protein fractions from mutant
muscle, p62 aggregates were observed in many myofibers (Fig-
ures S5G and S5I). Similarly, Lamp1/Lamp2-positive structures
accumulated in a few fibers but did not colocalize with p62
aggregates (Figures S5J and S5K). Lastly, the amount of ubiqui-
tinylated proteins was increased in TA muscle from starved
2-month-old (100 ± 4% in control; 122 ± 7% in mutant) and
6-month-old (100 ± 2% in control; 191 ± 17%** in mutant,
**p < 0.005) RAmKO mice (Figures S5L and S5M). Together,
these results suggest that lysosomal activity may be slowed
down in RAmKO muscles, thereby limiting the final degradation
steps of autophagy and resulting in the accumulation of auto-
phagic substrates.
Lastly, as mTOR complex 2 (mTORC2), characterized by the
rapamycin-insensitive companion of mTOR (rictor), was also
reported to indirectly regulate autophagy via Akt in muscle cells
(Mammucari et al., 2007), we examined whether mice specif-
ically depleted for rictor in skeletal muscle (RImKO; Bentzinger
et al., 2008) would show changes in autophagy. No difference
in the number of GFP-LC3 puncta was observed in muscles of
RImKOmice compared to control mice in basal and starved con-
ditions (Figures S5N and S5O). Furthermore, LC3I, LC3II, and
p62 levels in 3- and 6-month-old RImKO mice were similar to
control animals (Figures S5P and S5Q). These results indicate
that autophagy in skeletal muscle is not regulated by mTORC2.
Rapamycin Restores the Autophagy Flux and Reverses
Muscle Alterations in TSCmKO Mice
Having shown that mTORC1 inhibition is required and sufficient
to trigger autophagy induction, we assessed whether inhibition
of mTORC1would restore autophagy and reverse themyopathic
phenotype of TSCmKO mice. In TA muscle, rapamycin normal-
ized phospho-Akt and phospho-S6 levels in starved 2-month-
old and 12-month-old mutant mice, indicating that mTORC1
was efficiently inhibited by the treatment (Figure 6A). Rapamycin
treatment decreased the amount of p62 in both 2- and 12-
month-old TSCmKO mice and restored the conversion of LC3I
to LC3II and the number of GFP-LC3 puncta in starved TSCmKO
mice (Figures 6A–6C). Levels of phospho-Ulk1S757 and Beclin 1
were normalized by rapamycin (Figures 6A and S6A), while
mRNA expression of the autophagy-related genes in starved
mice was not significantly affected (Figures 6D and S6B). Similar
results were obtained in soleusmuscles (Figures S6C and S6D).
These results show that mTORC1 inhibition by rapamycin in
TSCmKO mice is sufficient to restore autophagy induction.
Morphological analyses of TA and soleusmuscles revealed an
improvement of the myopathy in 12-month-old TSCmKO mice
when treated with rapamycin (Figure 6E). In particular, fibers
with vacuoles or hematoxylin-positive inclusions were less
frequent, and the accumulation of p62 aggregates was strongly
reduced in rapamycin-treated mice (Figure 6E). Moreover, rapa-
mycin reversed, at least partially, the atrophy of type IIb fibers in
TA (Figure 6F) and the hypertrophy of type IIa/IIx fibers in soleus
(Figure S6E). Most importantly, rapamycin normalized mass,
specific twitch force (sPt), and specific tetanic force (sPo) of
the TSCmKO soleus muscle (Figures 6G and 6H). Altogether,
these data indicate that rapamycin is sufficient to ameliorate
the myopathy observed in old TSCmKO mice, which is likely
due to the normalization of the autophagy flux.ell Metabolism 17, 731–744, May 7, 2013 ª2013 Elsevier Inc. 739
Figure 5. Autophagy Is Induced in RAmKO Mice Despite Reduced FoxO3 Activity
(A) Immunoblots using antibodies that detect Akt and S6 protein and their phosphorylated forms show resistance of RAmKO (RA) TA to food intake and
deprivation compared to control (Ctrl). Data are normalized to a-actinin and are representative of three independent experiments; quantification is given in
Table S4.
(B) Transcript levels of MuRF1 and Atrogin1 in TA from starved RAmKO mice are reduced compared to starved control mice. Expressions are normalized to
b-actin levels. Values are mean ± SEM; **p < 0.05 compared to control mice under the same condition; $p < 0.05, $$p < 0.005 compared to same genotype in
basal conditions.
(legend continued on next page)
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Autophagy impairment has been positioned as a central path-
omechanism related to neurodegenerative diseases, cancer,
and aging-associated dysfunctions. By generating mice
depleted for TSC1 in skeletal muscle (TSCmKO), we show
that sustained activation of the mTORC1 pathway leads to a
late-onset myopathy with muscle atrophy and severe muscle
weakness. Previous reports established that excessive, as
well as insufficient, autophagy flux damage muscle tissue
(Mammucari et al., 2007; Masiero et al., 2009). Accordingly,
TSCmKO muscles progressively accumulate p62 aggregates,
vacuoles, and damaged organelles with age, supporting the
idea that muscle atrophy in TSCmKO mice is at least partly
caused by impaired autophagy flux. Soleus muscle was the
only muscle analyzed with increased muscle weight, but this
gain of mass was nonfunctional, as its force-drop was even
higher than in EDL muscle. Although slow muscles were
reported to have lower autophagy flux compared to fast
muscles (Ogata et al., 2010), soleus muscle was not spared
from the accumulation of autophagic substrates in TSCmKO
mice. Hence, whether the distinct muscle growth response to
mTORC1 activation relies on differential autophagy impairment
remains unclear, but one can hypothesize that it may be more
complex than a simple fast versus slow muscle distinction and
may also combine specific modulation of anabolism and pro-
teasomal activity.
Contrasting the current view that autophagy is independent
of mTORC1 in skeletal muscle and strictly depends on FoxO3
(Mammucari et al., 2007; Zhao et al., 2007), we find here that
sustained activation of mTORC1 blocks the induction of auto-
phagy, despite increased FoxO3 activity, both in vivo and
in vitro. As described in other cell types, this inhibitory effect
of mTORC1 on autophagy in skeletal muscle was related to
phosphorylation of Ulk1 protein at S757, which prevents its
activation by AMPK in response to energy deprivation (Kim
et al., 2011). Inhibition of mTORC1 with rapamycin or over-
expression of the Ulk1 mutant S757A in TSCmKO mice was
sufficient to restore autophagy in vivo. Inversely, the sustained
induction of autophagy in RAmKO mice, in spite of the strong
activation of Akt, indicates that LC3 lipidation is also dictated
by mTORC1 inactivation and does not require FoxO3 activa-
tion. This autophagy induction correlated with higher AMPK-
dependent phosphorylation of Ulk1 at S317, which is likely
facilitated by mTORC1 abrogation as established in mouse
embryonic fibroblast (MEF) cells (Kim et al., 2011). These seem-
ingly different results to previous studies conducted in muscle(C) Accumulation of p62 (arrow) is observed rarely in muscle fibers in 2-month
starvation. Scale bar = 50 mm.
(D) Two-month-old RAmKO (RA) and control (Ctrl) mice were submitted to fed, b
Notably, immunoblots of TA mutant muscle reveal stronger LC3I-to-LC3II con
a-actinin and represent three independent experiments; quantification is given in
(E and F) Quantification of the number of GFP puncta in TA muscle of GFP-LC3
starvation (E) and visualization of the GFP puncta in cross-sections (F). In basal c
than in control mice but fails to further increase upon starvation (St24). A volume u
*p < 0.05 compared to control mice in same conditions; $p < 0.05 compared to
(G) Expression of autophagy-related genes in TA from starved RAmKO mice is re
conditions. Expressions are normalized to b-actin levels. Values are mean ± SE
$$p < 0.005 compared to same genotype in basal conditions.
Clikely stem from experimental procedures, which may not
reproduce the blocking effect of mTORC1 (Mammucari et al.,
2007; Zhao et al., 2007). However, the described inability of
rapamycin to increase the number of autophagosomes in
mice that express a constitutively active form of Akt is more
surprising (Mammucari et al., 2007). This may be due to the
complete inhibition of the FoxO pathway, thereby constituting
a limiting factor for autophagy induction. In RAmKO mice,
expression of Bnip3 and Beclin 1 proteins, which are essential
for FoxO3-dependent activation of autophagy (Mammucari
et al., 2007; Grumati et al., 2010), was still detected, suggesting
that FoxO3 activity is not completely blocked. Nonetheless,
RAmKO mice did not respond to starvation by further inducing
autophagy, which may be due to the limited upregulation of
autophagy-related genes. Similarly, heterogeneous distribution
of autophagosomes in muscle fibers from starved RAmKO mice
and accumulation of p62 aggregates with age may reflect insuf-
ficient autophagy flux. Notably, we cannot rule out that the
degradation steps of autophagy are limited in RAmKO mice
due to restricted lysosomal activity, which may be related to
FoxO inhibition in these mice. Hence, our findings strongly
support the idea that constitutive autophagy, related to circa-
dian feeding and activity, depends on the inhibition of the
Akt/mTORC1 axis, a condition required for further stress-
induced autophagy associated with the AMPK/FoxO3 axis
(Sanchez et al., 2012). In this system, mTORC1 con-
stitutes the major upstream-limiting safety catch for autophagy
that coordinates changes in catabolism and anabolism in a
transcription-independent manner.
Growing evidence incriminates the decline of autophagy
capacity in the age-related dysfunction of several tissues (Salmi-
nen and Kaarniranta, 2009). Accordingly, the muscle phenotype
described in TSCmKOmice is reminiscent of age-related loss of
muscle mass and function, identified as sarcopenia. The
concomitant loss of fat and changes in plasma glucose levels
are also observed in mice with a muscle-specific deletion of
Atg7 in which autophagy in skeletal muscle is blocked (Kim
et al., 2013), suggesting that similar mechanisms may account
for the metabolic perturbation in TSCmKO mice. Notwith-
standing, it is now well established that restoring autophagy
flux, for instance by caloric restriction or by inhibiting the
mTORC1 pathway, is sufficient to reverse some age-related
alterations and to increase lifespan in different organisms
(Mizushima et al., 2008; Harrison et al., 2009; Wohlgemuth
et al., 2010). Consistently, rapamycin improves the morpholog-
ical and functional muscle phenotype of old TSCmKO mice.
This effect was not driven by indirect activation of FoxO3 through-old RAmKO mice in basal conditions and is slightly increased after 24 hr of
asal, or starved conditions (St24) with (+) or without () chloroquine treatment.
version, which is further increased with chloroquine. Data are normalized to
Table S4.
-expressing RAmKO and control (Ctrl) under basal conditions and after 24 hr
onditions, the number of GFP-positive puncta is significantly higher in RAmKO
nit (Vol) displayed in (E) corresponds to 3.63 105 mm3. Data are mean ± SEM;
same genotype in basal conditions. Scale bar = 50 mm (F).
duced compared to starved control mice but upregulated compared to basal
M; *p < 0.05 compared to control mice under the same condition; $p < 0.05,
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Figure 6. Rapamycin Restores Starvation-Induced Autophagy and Ameliorates the Muscle Phenotype in TSCmKO Mice
(A) Rapamycin (+) normalizes levels of phosphorylation (P) of Akt and S6 and reduces the accumulation of phospho (P)-Ulk1S757 and p62 in TA from 2-month-old
starved (St24) and from 12-month-old (M,month) TSCmKOmice. The treatment also promotes the conversion of LC3I to LC3II in starved TSCmKOmice. Data are
normalized to a-actinin and are representative of three independent experiments; for quantification, see Table S2.
(B and C) Rapamycin is sufficient to increase the number of GFP-positive puncta in TAmuscle from 2-month-old starved TSCmKOmice expressing GFP-LC3 (B).
Scale bar = 50 mm. GFP-LC3 puncta were quantified in a volume unit (Vol) of 3.6 3 105 mm3 (C). Values are mean ± SEM. *p < 0.05; **p < 0.005.
(D) Expression of the E3 ligase MuRF1 and the autophagy-related gene Gabarapl1 is unchanged in TA from rapamycin-treated (+) starved mice compared to
sham-treated () mice. Data are normalized to a-actinin and relative to control mice in basal conditions. Values are mean ± SEM.
(E) H&E and immunostaining against p62 show reduced accumulation of vacuolated fibers (arrow), intracellular inclusions (open arrow), and p62 aggregates in TA
from 12-month-old TSCmKO mice treated with rapamycin (+) compared to untreated () mutant mice. Scale bar = 100 mm.
(F) Rapamycin treatment for 10 or 21 days (d) ameliorates the atrophy of type IIb fibers, but not the hypertrophy of type IIa/IIx fibers, in TA from 12-month-old
TSCmKO mice. Values are mean ± SEM; *p < 0.05 compared to sham-treated TSCmKO mice.
(G and H) Muscle mass (G), specific twitch (sPt), and tetanic (sPo) forces (H) of soleusmuscle from 12-month-old rapamycin-treated TSCmKOmice are improved
compared to sham-treated mutant mice. Control values are indicated for reference by the dotted green line. Values are mean ± SEM; *p < 0.05; ***p < 0.0005.
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Akt tends to be more activated and autophagy-related genes
were unchanged. These results may foster the development of742 Cell Metabolism 17, 731–744, May 7, 2013 ª2013 Elsevier Inc.therapies modulating mTORC1 as a strategy for the treatment
of sarcopenia and for muscle pathologies linked to impaired
autophagy. Given our findings, therapeutic inhibition of mTORC1
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mTORC1 Inhibits Autophagy Induction in Musclewill only make sense in pathological conditions where autophagy
is prevented by hyperactivation of mTORC1. Accordingly, rapa-
mycin treatment of collagen VI-deficient mice, characterized by
increased Akt activation, was sufficient to restore autophagy and
partly ameliorated the phenotype of the animals (Grumati et al.,
2010). Other muscle pathologies with impaired autophagy
related to Akt/mTORC1 misregulation may constitute potential
targets for the therapeutic modulation of the mTORC1 pathway,




Generation and genotyping of RAmKO, RImKO, and GFP-LC3 transgenic
mice were described previously (Mizushima et al., 2004; Bentzinger et al.,
2008). TSCmKO mice were obtained by crossing Tsc1-floxed mice (Kwiat-
kowski et al., 2002) from Jackson Laboratory with transgenic mice express-
ing Cre recombinase under the control of the human skeletal actin promoter
(Schwander et al., 2003). For starvation experiments, mice were euthanized
in the following conditions: ad libitum; at 10 pm (fed) or 10 am (basal); or
after 12, 24, 36, or 48 hr with food deprivation (starved) but free access to
water. In some experiments, mice were intraperitoneally injected with
chloroquine (50 mg/kg; Sigma-Aldrich) or rapamycin (1.5 mg/kg; LC Labora-
tories) as described previously (Bodine et al., 2001; Grumati et al.,
2010). In vitro force measurements of soleus and EDL muscles were con-
ducted as described previously (Bentzinger et al., 2008). All procedures
were performed in accordance with the Swiss regulations for animal ex-
perimentation and approved by the veterinary commission of the Canton
Basel-Stadt.
In Vivo Muscle Electroporation
The constructs have been described previously (Kong et al., 2004; Bentzinger
et al., 2013) or are detailed in the Supplemental Experimental Procedures.
Plasmid for wild-type Ulk1 (Yan et al., 1998) was obtained from Addgene;
mutagenesis (S757A) was conducted with QuikChange II XL Site-Directed
Mutagenesis Kit (Agilent). Electroporation into muscle fibers was performed
as described before (Kong et al., 2004).
Isolated Single Fibers
Single muscle fibers were isolated from EDL and TA muscles as described
previously (Rosenblatt et al., 1995) and incubated for 4 hr in growth medium
or PBS before protein extraction or methanol fixation.
Transcript Expression Analyses
Gene expressionwas quantified by quantitative PCR. Results were normalized
to b-actin or a-actinin expression and relative to expression in control mice.
Primers are listed in Table S6.
Western Blotting
Proteins were extracted from TA and soleus muscles as described previously
(Bentzinger et al., 2008). The detergent-insoluble protein fraction was solubi-
lized in lysis buffer supplemented with 2% SDS. Antibodies used for immuno-
blotting are listed in the Supplemental Experimental Procedures.
Histology and Electron Microscopy
Inorganic colorations, immunostaining, and GFP-LC3 detection were con-
ducted on muscle cryosections as described previously (Mizushima et al.,
2004; Bentzinger et al., 2008). Antibodies are listed in the Supplemental Exper-
imental Procedures. Transmission electron microscopy was performed as
described (Moll et al., 2001).
Images and Statistical Analyses
Images were analyzed with the analySIS (Soft Imaging System) and Imaris
software. Results are expressed as mean ± SEM of independent animals,
with n (number of individual experiments) R 3. Statistical comparison of twoCconditions was performed using Student’s t test with a 0.05 level of confidence
accepted for statistical significance.
Detailed experimental procedures are given in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, six tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2013.03.015.
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